Press Releases

Filters
February 16, 2012

Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932

Read more
November 9, 2011

Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease

Read more
October 5, 2011

The Japanese Cancer Association and Debiopharm Group™ present Doctors Arakawa and Kurokawa with the 2011 ‘JCA-Mauvernay Award’for their innovative and…

Read more
September 8, 2011

Debiopharm Group™ presents the ‘Debiopharm Group™ Life Sciences Award 2011’ and two ‘Junior Debiopharm Group™ Awards 2011’ at the ISREC…

Read more
September 7, 2011

Debiopharm and Ascenta Therapeutics, Inc. announce an exclusive license agreement for the development and commercialization of the IAP (Inhibitor of…

Read more
September 1, 2011

Debiopharm Group™ s’installe dans son “Espace «après-demain»” au sein du quartier de l’innovation de l’EPFL

Read more
July 26, 2011

INC Research and Debiopharm Group ™ announce Strategic Partnership

Read more
July 14, 2011

Continuity as Debiopharm Group™ management moves forward

Read more
May 4, 2011

Debiopharm and Yale announce an exclusive license agreement for the development and commercialization of Debio 1036, a first-in-class inhibitor for…

Read more